Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/publications/12878-perioperative-chemoimmunotherapy-with-durvalumab-for-muscle-invasive-urothelial-carcinoma-primary-analysis-of-the-single-arm-phase-ii-trial-sakk-0617
https://forschung.kssg.ch/de/publications/12878-perioperative-chemoimmunotherapy-with-durvalumab-for-muscle-invasive-urothelial-carcinoma-primary-analysis-of-the-single-arm-phase-ii-trial-sakk-0617